Hanall Biopharma Strategic Asset Allocation Index
Hanall Biopharma strategic asset allocation index. Hanall Biopharma (009420) has a Strategic Asset Allocation Index of 11.4% as of December 2022. Strategic assets (PP&E of ₩19.13 Billion plus long-term investments of ₩-) total ₩19.13 Billion, measured against net assets of ₩168.26 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check 009420 intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Hanall Biopharma (2011–2022)
Strategic asset allocation index of Hanall Biopharma from 2011 to 2022. This chart shows how Hanall Biopharma's Strategic Asset Allocation Index has evolved across 12 annual periods from 2011 to 2022. As of December 2022, the index stands at 11.4%, representing strategic assets of ₩19.13 Billion against net assets of ₩168.26 Billion KRW.
Hanall Biopharma Strategic Asset Allocation Index by Year (2011–2022)
Hanall Biopharma strategic asset allocation index by year from 2011 to 2022. The table below presents the year-by-year Strategic Asset Allocation Index for Hanall Biopharma from 2011 to 2022, covering 12 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Hanall Biopharma (009420) total market value.
| Year | SAAI | Strategic Assets (KRW) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 11.4% | ₩19.13 Billion | ₩19.13 Billion | ₩- | ₩168.26 Billion | ▼ -0.3 pp |
| 2021 | 11.6% | ₩19.04 Billion | ₩19.04 Billion | ₩- | ₩163.49 Billion | ▲ +3.1 pp |
| 2020 | 8.5% | ₩15.48 Billion | ₩15.48 Billion | ₩- | ₩181.27 Billion | ▼ -14.9 pp |
| 2019 | 23.4% | ₩32.87 Billion | ₩14.94 Billion | ₩17.93 Billion | ₩140.42 Billion | ▲ +6.4 pp |
| 2018 | 17.0% | ₩19.91 Billion | ₩13.77 Billion | ₩6.14 Billion | ₩116.92 Billion | ▲ +3.4 pp |
| 2017 | 13.6% | ₩15.14 Billion | ₩13.38 Billion | ₩1.76 Billion | ₩111.20 Billion | ▼ -1.3 pp |
| 2016 | 14.9% | ₩15.56 Billion | ₩13.78 Billion | ₩1.78 Billion | ₩104.36 Billion | ▲ +1.0 pp |
| 2015 | 13.9% | ₩13.24 Billion | ₩12.18 Billion | ₩1.06 Billion | ₩95.22 Billion | ▼ -12.6 pp |
| 2014 | 26.5% | ₩12.12 Billion | ₩11.86 Billion | ₩264.91 Million | ₩45.81 Billion | ▲ +4.6 pp |
| 2013 | 21.8% | ₩13.01 Billion | ₩12.20 Billion | ₩805.28 Million | ₩59.63 Billion | ▲ +8.5 pp |
| 2012 | 13.3% | ₩10.50 Billion | ₩10.50 Billion | ₩- | ₩78.67 Billion | ▼ -5.9 pp |
| 2011 | 19.3% | ₩9.78 Billion | ₩9.78 Billion | ₩- | ₩50.70 Billion | — |